Spero Therapeutics, Inc. (SPRO) Capital expenditures 2016–2020
Spero Therapeutics, Inc. (SPRO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$157,000FY2020 · since FY2016: $830,000 → $157,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $157,000 | -50.0% |
| FY2019 | $314,000 | -87.1% |
| FY2018 | $2.4M | +8922.2% |
| FY2017 | $27,000 | -96.7% |
| FY2016 | $830,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice